Discovery offers new understanding of diabetes drug target

September 26, 2008

Team from University of Leicester reveal how the protein PPAR gamma binds to 8 fatty acids

Scientists at the University of Leicester have published findings about a new advance in the study of major diabetes drug target.

The advance - described by the researchers as 'very significant' - could lead to new drugs being developed to target a protein that plays a critical role in controlling the way the body breaks down sugar.

Professor John Schwabe and his team from the University of Leicester Department of Biochemistry (together with teams from Japan and Hungary) have been studying the protein, PPAR gamma. PPAR gamma is a major drug target for the treatment of type 2 diabetes. Although it was known how drugs are able to activate this protein, until this study, using the sophisticated technique of X-ray Crystallography, it was not clear how PPAR gamma is naturally activated in the body.

X-ray Crystallography is the principal method by which the detailed 3- dimensional structures of molecules - especially the molecules of living systems - have been discovered. It is achieved by firing X-rays at the target and creating its structures by analysing how the x-rays scatter into many different directions.

Through this method, the Leicester team have shown how PPAR gamma binds to eight different fatty acids, derived in part from what we eat. They found that many of these acids joined irreversibly with the protein and led to its long term activation. They have also shown that sometimes two fatty acids bind simultaneously, which might mean that PPAR gamma could be targeted by a mixture of drugs.

Professor John Schwabe, who led the Leicester project with his team, including Dr Toshimasa Itoh and Dr Louise Fairall, said: "The finding that natural activators for PPAR gamma couple irreversibly to the PPAR gamma receptor dramatically changes our understanding of how this receptor is activated.

"It may also allow for the design of novel pharmaceuticals that give longer term activation of PPAR gamma, at lower doses, without some of the side effects of the current generation of drugs."

Professor Schwabe said: "PPAR gamma is a critical player in the increasingly prevalent metabolic disease of type 2 diabetes which affects more than 180 million people worldwide (World Health Organisisation) and in the UK alone costs the NHS £9.6 million every day.

"PPARgamma is activated by two widely prescribed anti-diabetic insulin- sensitising drugs, Actos and Avandia. However the identity of the natural activators for PPAR gamma has remained unclear.

"Our breakthrough is important because it reveals for the first time that how this protein is activated by naturally-occuring fatty acids. This knowledge will help in the design of future novel pharmaceutical agents."

University of Leicester

---

---

	Diabetes Without Drugs: The 5-Step Program to Control Blood Sugar Naturally and Prevent Diabetes Complications by Suzy Cohen RPh (Author) Based on breakthrough studies, Cohen’s program reveals how people with diabetes can reduce their need for prescription medication and minimize the disease’s effect on the body. Most doctors consider diabetes a one-way street—once you have it, your only option is to manage the symptoms with a restricted diet, close monitoring of blood sugar, and expensive medications. Pharmacist Suzy Cohen shows that diabetes can be treated instead through safe, natural means, like food and vitamins, rather than strictly relying on prescription drugs. She shifts the focus away from glucose management to a whole body approach, using supplements, minerals, and dietary changes to lose weight, repair cell damage, improve insulin function, and reduce the side effects from prescription drugs, many of...
	Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes without Drugs by Neal D. Barnard (Author) Until Dr. Barnard’s scientific breakthrough, most health professionals believed that once you developed diabetes, you were stuck with it—and could anticipate one complication after another, from worsening eyesight and nerve symptoms to heart and kidney problems. But as this groundbreaking work reveals, this simply is not true. In a series of studies—the most recent funded by the National Institutes of Health—Dr. Barnard has shown that it is possible to repair insulin function and reverse type 2 diabetes. By following his scientifically proven, life-changing program, diabetics can control blood sugar three times more effectively than with the standard diet; and cut back on and in some cases eliminate medications while reducing the risk of diabetes complications. "The long overdue...
	Actos Diabetes Drug Adverse Affects by Online Legal Media This is a compilation of curated news from the LawyersandSettlements.com site regarding the potential adverse affects of using Actos to treat diabetes. Actos (pioglitazone hydrochloride) is a member of a class of drugs known as thiazolidinediones, which have been linked to liver and cardiovascular issues. Actos side effects include increased risk of congestive heart failure (CHF), increased risk of rare but serious liver problems, an increased risk of fractures, and an increased risk for bladder cancer. The link between Actos and heart failure is strong enough that in 2007 the FDA increased the warnings on the drug concerning congestive heart failure. Actos is used to treat type 2 diabetes. LawyersandSettlements.com has reported on developments regarding Actos side...
	Blood Sugar 101: What They Don't Tell You About Diabetes by Technion Books Based on the award winning Bloodsugar101.com web site, this book explains what peer-reviewed research published in top medical journals has to say about: + What is a normal blood sugar? + How does diabetes develop? + What really causes diabetes? + What blood sugar levels cause complications? + Must you deteriorate? + What diet is right for you? + How can you make that diet work? + What medications are safe? + What supplements lower blood sugar? Written in clear and understandable language, this book provides all the tools needed to understand how blood sugar works and achieve blood sugar health. "this book should be read by all diabetics because of the valuable material that cannot be found elsewhere." --Dr....
	Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes Without Drugs by Neal D. Barnard (Author), Bryanna Clark Grogan (Author) Offering new hope to millions, this new nutritional approach to diabetes will dramatically alter the way we think about treating the disease Until now, most health professionals have considered diabetes a one-way street. Once you developed it, you were stuck with it—and you could anticipate one complication after another, from worsening eyesight and nerve symptoms to heart and kidney problems. Enter Dr. Neal Barnard, who through a series of groundbreaking studies, the latest funded by the National Institutes for Health, has shown it doesn’t have to be that way. By following the diet outlined in this book, readers can control blood sugar three times more effectively than with the American Diabetes Association’s diet and, beyond that, improve their bodies’ ability to...
	Losing Weight with Your Diabetes Medication: How Byetta and Other Drugs Can Help You Lose More Weight than You Ever Thought Possible (Marlowe Diabetes Library) by David Mendosa (Author), M.D. Joe Prendergast (Foreword) Losing weight can make managing your diabetes easier while preventing and improving-even possibly reversing-common diabetes-related complications.Countless people with diabetes face the challenge of controlling their weight while successfully managing their medical condition-because many diabetes drugs actually promote weight gain. In the first-ever investigation of its kind, Losing Weight with Your Diabetes Medication clearly lays out everything you need to know about your treatment options and how they affect your weight, as well as a 360-degree analysis of cutting-edge new drugs like Byetta that are revolutionizing diabetes care. One of North America’s leading diabetes journalists and patient-advocates, David Mendosa provides this information alongside everything you need to know to...
	101 Medication Tips for People With Diabetes (American Diabetes Association & American Dietetic Association) by Betsy Carlisle (Author) For people with diabetes, there are a bewildering number of medications must be carefully integrated with diet and exercise. Readers will find answers to the most commonly asked questions, including the difference between regular and Lispro insulin, the main side effects of drugs used to treat Type 2 diabetes, and more.
	Glyburide for gestational diabetes.(DRUGS, PREGNANCY, AND LACTATION): An article from: Internal Medicine News by Gideon Koren (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on March 15, 2007. The length of the article is 799 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Glyburide for gestational diabetes.(DRUGS, PREGNANCY, AND LACTATION) Author: Gideon Koren Publication: Internal Medicine News (Magazine/Journal) Date: March 15, 2007 Publisher: Thomson Gale Volume: 40 Issue: 6 Page: 26(1) Distributed by Thomson...
	HYPERTENSION IN PATIENTS WITH DIABETES: Strategies for drug therapy to reduce complications (Postgraduate Medicine) by JTE Multimedia High blood pressure presents a major threat in patients with either type 1 or type 2 diabetes. It greatly increases the risks for such complications as end-stage renal disease, coronary artery disease, stroke, peripheral vascular disease, and diabetic retinopathy. Drug therapy can help avert these complications but often is underutilized as a treatment option. In this article, the authors discuss pharmacologic interventions and how best to use them in diabetic patients with hypertension. In the February issue, the authors discussed why aggressive treatment is essential, and in March, they examined the perceived and real barriers to effective treatment. Sowers JR, Williams M, Epstein M, et al. Hypertension in patients with diabetes: strategies for drug therapy to reduce complications.
	Competitor Analysis: Emerging Diabetes Drugs by La Merie Publishing (Author) The present Competitive Intelligence Report about Emerging Diabetes Drugs provides a competitor evaluation in the field of novel molecules against a series of novel targets being developed for treatment of type 1 or 2 diabetes as of April 2011. Pharmacologic approaches include SGLT inhibitors, glucokinase activators, 11beta-HSD1 inhibitors and many others. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. The report includes a compilation of currently active projects in research and development of novel molecules for treatment of type 1 and 2...